patient_seminar

Patient Seminar 2011

For the first time during the ESGO17 Congress in Milano, ESGO organised a seminar for European patient groups with an interest in gynaecological cancers. Fifty participants, including 38 representatives of patient organisations, attended this first EGSO patient seminar. After presentations on current inequalities and future innovation in gynaecological cancer, patient organisations shared their achievements and challenges, and discussed how to work with each other and ESGO to improve care and outcomes for women with gynaecological cancer in Europe.

 

 

ENGAGe is planning another patient seminar during the ESGO18 Congress in Liverpool.

2011 Patient Seminar Documentation & Photos

Take a look at the 2011 Patient Seminar Program, Report and Photos.

 

Patient Seminar Program

 

Co chairs, Ate van der Zee, Immediate Past President, ESGO & Louise Bayne, CEO Ovacome UK, opening the ESGO Patient Seminar

 

Ate van der Zee, Immediate Past President, ESGO introducing gynaecological cancers.

 

John Butler, International Cancer Benchmarking Partnership, Gynaecological Oncology Fellow St Bartholomews and Royal Marsden Hospital, UK talking about the inequalities in survival of gynaecological cancers in Europe today.

 

Ate van der Zee, Immediate Past President, ESGO talking to ESGO Patient Seminar participants.

 

From left to right : Isabel Mortara, Executive Director, Kenes Associations Worldwide ; Ate van der Zee, Immediate Past President, ESGO ; Louise Bayne, CEO, Ovacome UK and Jan Geissler, CEO Patvocates and Co-Founder CML Advocates Network.

 

ESGO Patient Seminar Participants enjoying a coffee break.

 

Session speakers during the Q & A. From left to right: Flavia Bideri, ACTO onlus, Italy (Patient Participation in Research) ; Jalid Sehouli, Charité Universitätsmedizin Berlin, Germany (Current options and the ongoing future of clinical trials) ; Emma Elliot, National Forum of Gynaecological Oncology Nurses, UK (Multidisciplinary treatment in gynaecological cancer) and Frederic Amant, UZ Gasthuisberg/Katholieke Universiteit Leuven, Belgium (Innovation, target therapies and individualised medicine)

 

Louise Bayne, CEO Ovacome, UK, speaking about their leading initiatives in Ovarian cancer.

 

Doris Schmitt, PATH, Germany presenting the Patient-driven breast cancer tumour bank as a possible model for gynaecological cancers.

 

Paola Mosconi, Istituto di Ricerche Farmacologiche Mario Negri, Italy speaking about ‘From patient literacy to advocacy’.

 

From left to right: Isabel Mortara, Executive Director, Kenes Associations Worldwide ; Ate van der Zee, Immediate Past President, ESGO and Nicoletta Colombo, ESGO President.

 

Laura Jakovljevic, from Roche, a sponsor of the patient seminar, networking during the coffee break.

 

Karen Orloff Kaplan, CEO, Ovarian Cancer National Alliance, USA, networking during the coffee break.

 

Pam Ganju from Morphotek , a sponsor of the patient seminar, networking during the coffee break.

 

Paola Casali (right), Istituto Nazionale dei Tumori, Milan, Italy, gave a presentation in relation to the rare cancer perspective during the afternoon session.

 

Susanna Leto, from Novartis, a sponsor of the patient seminar and Jean Mossman, Roche enjoying a well deserved coffee.

 

Participants networking during the coffee break.

 

Nicoletta Colombo, ESGO President, closing the Patient Seminar and calling on patient groups to work together with ESGO to give more attention to gynaecological cancer in Europe.

You May Also Like

patient_seminar

Patient Seminar

Vienna, 2017

Read More

fact_sheets_on_each_cancer

Raise Awareness

Cancer Fact Sheets

Read More

empowering_0

Advocacy Toolkit

Designed For you! 

Read More

1233

Patient Stories

ENGAGe Blog

Read More